Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

57.10 +0.22 (+0.39%)
Streaming Delayed Price Updated: 9:49 AM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
News headline image
2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗
This juicy upside potential comes at a cost. 
Via The Motley Fool
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
This company's first product has started to generate revenue. 
Via The Motley Fool
Topics ETFs
News headline image
The Best Stocks to Buy With $1,000 Right Now ↗
It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the long run. 
Via The Motley Fool
Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70% ↗
Via Stocktwits
News headline image
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of... 
Via MarketMinute
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
These stocks both have advanced in the double-digits in recent months. 
Via The Motley Fool
News headline image
1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗
This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy? 
Via The Motley Fool
News headline image
The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? ↗
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial ↗
CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its gene editing platform. 
Via Benzinga
News headline image
Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
The companies are working on one-and-done treatments for diseases tied to genetic problems. 
Via Investor's Business Daily
Topics Death
News headline image
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗
The company remains confident in its other gene-editing product, which would treat a swelling disorder. 
Via Investor's Business Daily
Topics Death
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as... 
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
News headline image
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗
Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Other key trades were also made, including buying shares in CRISPR and Beam... 
Via Benzinga
News headline image
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now ↗
It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event. 
Via Benzinga
News headline image
2 Soaring Cathie Wood Stocks to Buy and Hold ↗
These companies' market-beating fuel hasn't run out yet. 
Via The Motley Fool
News headline image
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. ↗
CRISPR Therapeutics is a promising mid-cap biotech stock with an approved product in its portfolio. 
Via The Motley Fool
News headline image
3 Monster Stocks to Hold for the Next 10 Years ↗
Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the time. Every now and then, though, the right opportunity comes along. 
Via The Motley Fool
News headline image
4 Healthcare Stocks to Buy Now ↗
As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗
These biotechs could finally come into their own by the end of the decade. 
Via The Motley Fool
Topics Government World Trade
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for... 
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
News headline image
3 Growth Stocks That Could Be 10-Baggers in 10 Years ↗
Air taxis, quantum computing, and gene editing are all promising technologies to invest in for the long haul. 
Via The Motley Fool
News headline image
Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗
These stocks could see growth take off over the next few years. 
Via The Motley Fool
News headline image
Could This Beaten-Down Stock Help You Become a Millionaire? ↗
The company would need to maintain the strong momentum it's had this year for a long time. 
Via The Motley Fool
Topics ETFs
News headline image
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.